Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Category Archives: Events
Hot Topics at HBA
The 2009 Healthcare Businesswomen’s Association leadership conference is officially underway in sunny California. Last night, festivities got underway with a welcome reception for attendees followed by a “Taste of San Francisco,” which featured lively entertainment and regional cuisine.
I had the opportunity to catch up with a few seasoned participants who are widely known throughout the [...]
Connect with a Click of the Mouse
Thanks to Google, Facebook, and Twitter, the Internet has become the e-Patient’s No. 1 destination for seeking health information, and industry was all “a tweet” about it at this year’s e-Patient Connections Conference.
More than 250 people were in attendance for the two-day event, which included pharma marketers, brand managers, and patient education specialists who shared [...]
Also posted in E-Media Tagged e-Patient Connections Conference, Facebook, Google, Health care, Marketing, Marketing strategy, Online Communities, Pharma, Social network, Twitter Leave a comment
Pharma Celebrates its Own
At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage.
“The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon Health [...]

JP Morgan Healthcare Conference Marked by Hesitant Optimism